Yixintang Pharmaceutical Group Co., Ltd. (SHE:002727)
China flag China · Delayed Price · Currency is CNY
13.48
-0.26 (-1.89%)
Nov 18, 2026, 3:04 PM CST

SHE:002727 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
7,7397,3837,62513,80318,78222,959
Market Cap Growth
-4.87%-3.16%-44.76%-26.51%-18.19%15.78%
Enterprise Value
6,6267,1567,67913,71719,10123,481
Last Close Price
13.7412.4012.1721.2528.4834.26

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
20.3628.0366.8025.1218.6024.91
Forward PE
14.5612.4310.1713.0016.5919.48
PS Ratio
0.460.430.420.791.081.57
PB Ratio
1.050.991.001.752.503.44
P/TBV Ratio
1.511.461.442.333.204.52
P/FCF Ratio
4.265.455.207.418.7416.40
P/OCF Ratio
3.664.524.436.537.5212.81
PEG Ratio
-3.483.480.730.980.93

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
EV/Sales Ratio
0.390.410.430.791.101.61
EV/EBITDA Ratio
3.6111.2415.2614.1613.3418.30
EV/EBIT Ratio
10.6413.5420.0416.2514.5019.81
EV/FCF Ratio
3.655.285.247.378.8916.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Debt / Equity Ratio
0.300.360.400.380.410.44
Debt / EBITDA Ratio
1.221.501.851.501.331.28
Debt / FCF Ratio
1.241.962.071.611.442.08
Net Debt / Equity Ratio
-0.17-0.05-0.05-0.11-0.060.06
Net Debt / EBITDA Ratio
-1.74-0.64-0.75-0.93-0.300.29
Net Debt / FCF Ratio
-0.69-0.30-0.26-0.48-0.200.27
Asset Turnover
1.091.071.081.061.141.23
Inventory Turnover
3.303.053.133.263.433.38
Quick Ratio
0.760.720.700.800.820.70
Current Ratio
1.341.301.271.371.381.31
Return on Equity (ROE)
4.98%3.60%1.42%7.28%14.27%14.73%
Return on Assets (ROA)
2.52%2.04%1.43%3.21%5.40%6.26%
Return on Invested Capital (ROIC)
6.63%4.93%2.86%9.56%15.28%20.17%
Return on Capital Employed (ROCE)
7.40%6.00%4.20%8.90%14.20%14.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Earnings Yield
4.91%3.57%1.50%3.98%5.38%4.01%
FCF Yield
23.50%18.35%19.22%13.49%11.44%6.10%
Dividend Yield
2.97%3.11%2.30%1.73%1.27%0.78%
Payout Ratio
65.27%115.74%228.27%47.40%18.97%19.63%
Buyback Yield / Dilution
2.86%2.70%0.76%-0.27%-0.50%-3.32%
Total Shareholder Return
5.80%5.81%3.06%1.46%0.77%-2.54%